Terms: = Leukemia AND PTPRC, LCA, 5788, ENSG00000081237, T200, GP180, B220, LY5, CD45 AND Staging
9 results:
1. Implementation of Mass Cytometry for Immunoprofiling of Patients with Solid Tumors.
Poláková I; Pelák O; Thürner D; Pokrývková B; Tachezy R; Kalina T; Šmahel M
J Immunol Res; 2019; 2019():6705949. PubMed ID: 30886872
[TBL] [Abstract] [Full Text] [Related]
2. A case of secondary plasma cell leukemia resistant to novel agents, in which stringent complete remission was achieved and maintained for a long period of time after VAD therapy and tandem autologous transplantation.
Sekiguchi Y; Shimada A; Wakabayashi M; Sugimoto K; Tomita S; Izumi H; Nakamura N; Sawada T; Ohta Y; Komatsu N; Noguchi M
Int J Clin Exp Pathol; 2014; 7(9):6313-22. PubMed ID: 25337285
[TBL] [Abstract] [Full Text] [Related]
3. Phospho-flow detection of constitutive and cytokine-induced pSTAT3/5, pAKT and pERK expression highlights novel prognostic biomarkers for patients with multiple myeloma.
Brown R; Yang S; Weatherburn C; Gibson J; Ho PJ; Suen H; Hart D; Joshua D
Leukemia; 2015 Feb; 29(2):483-90. PubMed ID: 24990616
[TBL] [Abstract] [Full Text] [Related]
4. Cell surface phenotype profiles distinguish stable and progressive chronic lymphocytic leukemia.
Huang PY; Best OG; Almazi JG; Belov L; Davis ZA; Majid A; Dyer MJ; Pascovici D; Mulligan SP; Christopherson RI
Leuk Lymphoma; 2014 Sep; 55(9):2085-92. PubMed ID: 24289109
[TBL] [Abstract] [Full Text] [Related]
5. The specificity of immunophenotypic alterations in blasts in nonacute myeloid disorders.
Harrington A; Olteanu H; Kroft S
Am J Clin Pathol; 2010 Nov; 134(5):749-61. PubMed ID: 20959658
[TBL] [Abstract] [Full Text] [Related]
6. Flow cytometry as an adjunct to cytomorphologic analysis of serous effusions.
Czader M; Ali SZ
Diagn Cytopathol; 2003 Aug; 29(2):74-8. PubMed ID: 12889043
[TBL] [Abstract] [Full Text] [Related]
7. Flow cytometric immunophenotyping test for staging/monitoring neuroblastoma patients.
Warzynski MJ; Graham DM; Axtell RA; Higgins JV; Hammers YA
Cytometry; 2002 Dec; 50(6):298-304. PubMed ID: 12497591
[TBL] [Abstract] [Full Text] [Related]
8. Optimal number of reagents required to evaluate hematolymphoid neoplasias: results of an international consensus meeting.
Braylan RC; Orfao A; Borowitz MJ; Davis BH
Cytometry; 2001 Feb; 46(1):23-7. PubMed ID: 11241503
[TBL] [Abstract] [Full Text] [Related]
9. Expression of cd45 isoforms in chronic B-cell leukaemias.
Zola H; Siderius N; Flego L; Sparrow R; van der Weyden MB; Nimmo J; Hart DN; Houghton S; Boyd AW
Leuk Res; 1993 Mar; 17(3):209-16. PubMed ID: 7680734
[TBL] [Abstract] [Full Text] [Related]
